These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

101 related items for PubMed ID: 19064293

  • 1. Mortality and morbidity of non-systolic heart failure treated with angiotensin-converting enzyme inhibitors: a propensity-adjusted case-control study.
    Gomez-Soto FM, Romero SP, Bernal JA, Escobar MA, Puerto JL, Andrey JL, Almenara J, Gomez F.
    Int J Cardiol; 2010 Mar 18; 139(3):276-82. PubMed ID: 19064293
    [Abstract] [Full Text] [Related]

  • 2. Mortality and morbidity of newly diagnosed heart failure with preserved systolic function treated with β-blockers: a propensity-adjusted case-control populational study.
    Gomez-Soto FM, Romero SP, Bernal JA, Escobar MA, Puerto JL, Andrey JL, Almenara J, Gomez F.
    Int J Cardiol; 2011 Jan 07; 146(1):51-5. PubMed ID: 19573938
    [Abstract] [Full Text] [Related]

  • 3. Characteristics, treatments, and outcomes of patients with preserved systolic function hospitalized for heart failure: a report from the OPTIMIZE-HF Registry.
    Fonarow GC, Stough WG, Abraham WT, Albert NM, Gheorghiade M, Greenberg BH, O'Connor CM, Sun JL, Yancy CW, Young JB, OPTIMIZE-HF Investigators and Hospitals.
    J Am Coll Cardiol; 2007 Aug 21; 50(8):768-77. PubMed ID: 17707182
    [Abstract] [Full Text] [Related]

  • 4. Effect of certain angiotensin-converting enzyme inhibitors on mortality in heart failure: a multiple-propensity analysis.
    Chitnis AS, Aparasu RR, Chen H, Johnson ML.
    Res Social Adm Pharm; 2012 Aug 21; 8(2):145-56. PubMed ID: 21511540
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Mortality of newly diagnosed heart failure treated with amiodarone A propensity-matched study.
    Andrey JL, Gomez-Soto FM, Romero SP, Escobar MA, García-Egido AA, Garcia-Arjona R, Gomez F, GAMIC (Grupo para Atencion Medica Integrada de Cadiz).
    Int J Cardiol; 2011 Sep 01; 151(2):175-81. PubMed ID: 20550974
    [Abstract] [Full Text] [Related]

  • 8. Mortality and morbidity of newly diagnosed heart failure treated with statins: a propensity-adjusted cohort study.
    Gomez-Soto FM, Romero SP, Bernal JA, Escobar MA, Puerto JL, Andrey JL, Ruiz P, Gomez F.
    Int J Cardiol; 2010 Apr 15; 140(2):210-8. PubMed ID: 19106008
    [Abstract] [Full Text] [Related]

  • 9. Treatment of heart failure with preserved systolic function.
    de Groote P, Herpin D, Diévart F, Hanon O, Trochu JN, Artigou JY, Galinier M, Habib G, Juillière Y, Neuder Y, Roudaut R, Komajda M.
    Arch Cardiovasc Dis; 2008 May 15; 101(5):361-72. PubMed ID: 18656095
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Prevalence, clinical characteristics, quality of life, and prognosis of patients with congestive heart failure and isolated left ventricular diastolic dysfunction.
    Badano LP, Albanese MC, De Biaggio P, Rozbowsky P, Miani D, Fresco C, Fioretti PM.
    J Am Soc Echocardiogr; 2004 Mar 15; 17(3):253-61. PubMed ID: 14981424
    [Abstract] [Full Text] [Related]

  • 12. Effect of statins, angiotensin-converting enzyme inhibitors, and beta blockers on survival in patients >or=65 years of age with heart failure and preserved left ventricular systolic function.
    Shah R, Wang Y, Foody JM.
    Am J Cardiol; 2008 Jan 15; 101(2):217-22. PubMed ID: 18178410
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients with congestive heart failure: an observational study of treatment rates and clinical outcome.
    Gotsman I, Rubonivich S, Azaz-Livshits T.
    Isr Med Assoc J; 2008 Mar 15; 10(3):214-8. PubMed ID: 18494235
    [Abstract] [Full Text] [Related]

  • 15. Retrospective claims database analysis to determine relationship between renin-angiotensin system agents, rehospitalization, and health care costs in patients with heart failure or myocardial infarction.
    Sun SX, Ye X, Lee KY, Dupclay L, Plauschinat C.
    Clin Ther; 2008 Mar 15; 30 Pt 2():2217-27. PubMed ID: 19281916
    [Abstract] [Full Text] [Related]

  • 16. Angiotensin-converting enzyme inhibitors prescription is associated with longer survival among patients hospitalized for congestive heart failure who have preserved systolic function: a long-term follow-up study.
    Grigorian Shamagian L, Roman AV, Ramos PM, Veloso PR, Bandin Dieguez MA, Gonzalez-Juanatey JR.
    J Card Fail; 2006 Mar 15; 12(2):128-33. PubMed ID: 16520261
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Drug therapy for chronic heart failure due to left ventricular systolic dysfunction: a review. III. Angiotensin-converting enzyme inhibitors.
    Ascenção R, Fortuna P, Reis I, Carneiro AV.
    Rev Port Cardiol; 2008 Sep 15; 27(9):1169-87. PubMed ID: 19044179
    [Abstract] [Full Text] [Related]

  • 19. Effect of Angiotensin-converting enzyme inhibition on one-year mortality and frequency of repeat acute myocardial infarction in patients with acute myocardial infarction.
    Milonas C, Jernberg T, Lindbäck J, Agewall S, Wallentin L, Stenestrand U, RIKS-HIA Group.
    Am J Cardiol; 2010 May 01; 105(9):1229-34. PubMed ID: 20403471
    [Abstract] [Full Text] [Related]

  • 20. Renal insufficiency as an independent predictor of mortality among women with heart failure.
    Bibbins-Domingo K, Lin F, Vittinghoff E, Barrett-Connor E, Grady D, Shlipak MG.
    J Am Coll Cardiol; 2004 Oct 19; 44(8):1593-600. PubMed ID: 15489091
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.